Finance Minister Nirmala Sitharaman presented the Union Budget 2025, highlighting measures to enhance healthcare affordability. Key initiatives include the exemption of 36 lifesaving drugs from Basic Customs Duty, and 37 more medicines from the same duty along with the introduction of patient assistance programmes providing free treatments.
from Healthcare/Biotech-Industry-Economic...
Budget may roll out HPV jab for cervical cancer
The Union budget may announce the rollout of the human papillomavirus (HPV) vaccine for cervical cancer prevention under the national immunisation programme. This move aligns with FM Nirmala Sitharaman's focus on cervical cancer vaccination, potentially providing the vaccine, currently available only in private hospitals at high costs, to more girls.
from...
Aerial angels: How drones can save your life
The Economic Survey 2024-25 highlighted how drones can address quality, accessibility, and affordability issues in India's healthcare. Projects like ‘Medicines from the Sky’ and ‘i-DRONE’ have already demonstrated their potential in a big way, cutting delivery times drastically and improving emergency responses, showcasing their role in saving lives.
from...
Apollo Hospitals, Hackensack Meridian announce collaboration
Apollo Hospitals Group has teamed up with Hackensack Meridian Health to develop innovative healthcare solutions. They aim to enhance patient care, improve affordability, and promote community health through joint initiatives. Key focus areas include addressing workforce shortages and oncology collaboration. This partnership seeks to leverage mutual...
This New Year explore the ABCD of diabetes
Diabetes and heart health are influenced by A1C, body weight, cardiovascular health, and the duration of diabetes. Excess weight, especially around the waist, increases the risk for heart disease and makes diabetes management tougher. Losing 5-10% of body weight can significantly improve both heart and blood sugar levels. Small health changes now can...
Roche Pharma India to appoint Rajwinder Mehdwan as country general manager
Roche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simpson Emmanuel. Rajji brings over 20 years of healthcare industry experience and has held various leadership roles at Roche and Johnson & Johnson.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/pKPmLlZ
via...
Budget 2025: Will FM Sitharaman give India’s healthcare sector the boost it desperately needs?
Union Budget: India's healthcare sector anticipates major support from the Union Budget 2025, with expectations for increased allocations to meet National Health Policy goals. Addressing disparities between urban and rural healthcare, and offering tax exemptions and higher insurance coverage are critical to enhance healthcare access for the 'missing...
Cipla sees no major impact on biz from Donald Trump admin's decision to pause foreign aid: Umang Vohra
Cipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the Trump administration's decision to pause foreign aid, including PEPFAR. The company's sales from PEPFAR are below $5 million, with low margins. Cipla's reduced dependence on tenders and significant US investments have de-risked...
Medicine e-tailer Sastasundar says its deal with Flipkart is now over
Flipkart has ended its partnership with Sastasundar in the online pharmacy and healthcare sector. Sastasundar has regained its brand's intellectual property rights and plans to launch its own app. This follows Flipkart’s decision to exit the health business. The transaction resulted in a one-time technical accounting loss for Sastasundar Ventures.
from...
Ophthalmic devices maker Appasamy appoints Annaswamy Vaidheesh as non-executive chairman
Appasamy Associates has appointed Annaswamy Vaidheesh as its non-executive chairman. With over 35 years of experience in the healthcare and med-tech industry, Vaidheesh brings valuable insights to the company. His strategic vision aims to drive growth, innovation, and global expansion in ophthalmic equipment and devices.
from Healthcare/Biotech-Industry-Economic...
Union Budget: Will India’s life sciences sector get the prescription for success?
Union Budget 2025: India's life sciences sector expects government reforms in the upcoming Union Budget to support growth and innovation. Key requests include incentives for R&D and domestic manufacturing, API infrastructure development, and AI investment in drug discovery. The sector also seeks increased healthcare spending and steps towards Universal...
Guillain-Barré Syndrome: What is it, what are the key symptoms, and are you at risk?
Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder affecting the nervous system, causing muscle weakness and paralysis. Learn about symptoms, treatment, prevention, and rising cases in Maharashtra.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8zl6JBf
via IFT...
Health Ministry sends team to Pune amid surge in Guillain-Barré Syndrome cases
A high-level team has been sent to Pune by the Union Ministry of Health and Family Welfare to address the surge in Guillain Barre Syndrome (GBS) cases. With over 100 cases reported and one suspected death, the team will assist the State health authorities with public health interventions and management.
from Healthcare/Biotech-Industry-Economic Times...
Policybazaar's parent firm eyes 25% stake in PB Healthcare; to invest Rs 860 cr for establishing hospitals
PB Fintech, the parent company of Policybazaar, invests Rs 860 crore for a 25% stake in PB Healthcare, aiming to establish hospitals with 1,000 beds in its first year. The venture will ensure cashless treatment without pre-authorisation, aiming to tackle rising healthcare costs. Initially, hospitals will be set up around NCR before expanding across...
China+1 opens larger share for India in global pharma manufacturing beyond generics: BCG report
India is set to capture a larger share of the global pharmaceutical market beyond generics, driven by the "China+1" strategy as companies diversify from China. Investments are pouring into India's affordable pharma services and growing infrastructure. India and Singapore are leading hubs for healthcare innovation, with Asia's healthcare market projected...
Pharma companies may get time till December to comply with schedule M norms
The government may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025. A final notification is expected soon, allowing MSMEs additional time to upgrade facilities.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hplYXr3
via IFT...
Budget 2025: SBI urges higher healthcare spending, uniform GST on medical devices and tax exemptions
The Union Government's Budget 2025 should focus on revitalizing the insurance and healthcare sectors. Suggestions include exempting GST and taxes on term and health insurance premiums, increasing the healthcare budget to 5% of GDP, and rationalizing GST rates on medical devices. These measures aim to enhance insurance penetration and bolster healthcare...
Drug quality, ease of doing biz to top govt-pharma companies' talks
The health ministry is set to meet pharma industry representatives to discuss improving drug quality after several instances of exports failing standards. The meeting on January 31 will also address ease of business concerns. Inspections have intensified following WHO's link between Indian cough syrups and deaths in Gambia and a report highlighting...
Union Budget 2025: Pharma, healthcare sectors seek 3 per cent hike in budget allocation
Budget: The Indian pharmaceutical and healthcare industry seeks increased government support in the Union Budget 2025, including a 2.50-3% rise in healthcare budget allocation, re-introduction of weighted average tax benefits for R&D, and reduced GST on health insurance premiums. This support aims to enhance infrastructure and affordability, thus...
Diabetes, heart, and kidneys: The hidden links you can’t afford to ignore
Diabetes impacts not just blood sugar but also the heart and kidneys. High sugar levels strain these organs, causing complications. Regular checkups, healthy lifestyle choices, and weight management are vital for minimizing risks and managing health effectively. Early detection and personalized treatments can significantly improve outcomes for people...
Strategy is to first serve India's vaccine needs and then move on to exports, says Adar Poonawalla
Serum Institute of India is planning to introduce chikungunya and monkeypox vaccines in about a year and a half and a dengue vaccine in approximately three years. The company is focusing on vaccine development and aims to supply new vaccines globally after meeting India's needs. The investment in Karan Johar's Dharma Productions reflects their broader...
NMC starts probe against doctors over AbbVie-sponsored foreign trips
The National Medical Commission (NMC) initiates an investigation into doctors whose foreign trips, funded by AbbVie Healthcare, breached the Uniform Code for Pharmaceutical Practices. AbbVie spent over a crore on travel for 30 doctors to Monaco and Paris, prompting scrutiny and potential disciplinary action for professional misconduct.
from Healthcare/Biotech-Industry-Economic...
Dr Reddy's CEO 'optimistic' about Trump administration, says our positioning of India is favourable
Dr Reddy's Laboratories CEO expressed optimism about the Trump administration, projecting an edge due to ongoing U.S.-China tensions. The company's U.S. revenues increased slightly due to new launches despite facing pricing pressures. Consolidated net profit rose by 2% for the third quarter of 2024, driven by strong performance across markets.
from...
Bankruptcy Court approves listed-firm parental drugs India’s acquisition by IHL Lifescience
The Mumbai bankruptcy court has approved IHL Lifesciences' acquisition of Parental Drugs India Ltd. The resolution plan received 100% approval from the creditors. IHL Lifesciences will pay Rs 90 crore to acquire the company, which has liabilities of Rs 1,287 crore. This acquisition comes after Parental Drugs defaulted on a Rs 196 crore payment to Punjab...
Mumbai's Lilavati Hospital to invest Rs 800 crore to build 300 bed cancer centre in Bandra
Lilavati Hospital & Research Centre is set to invest Rs 800 crore in a new 300-bed state-of-the-art cancer hospital in Bandra, Mumbai. The facility will span 3,50,000 square feet, close to the existing Lilavati Hospital. Funding will be sourced through donations and bank debt, with groundbreaking planned in the coming months and operations starting...
Zydus receives USFDA Orphan Drug Designation for Usnoflast to treat ALS
Zydus Lifesciences announced that the USFDA granted Orphan Drug Designation to Usnoflast, a novel oral NLRP3 inhibitor, for treating amyotrophic lateral sclerosis (ALS), a rare fatal neurodegenerative disease. Clinical trials indicate promising results, and further trials are planned. ALS affects over 30,000 people in the US annually.
from Healthcare/Biotech-Industry-Economic...
Centre to expand network of stroke units across country
Around 500 stroke units are operational in India, with plans to expand access to specialized care further. Union Health Secretary Punya Salila Srivastava highlighted the government's commitment to stroke prevention and control of non-communicable diseases, emphasizing the significant role of Ayushman Bharat in providing financial protection and health...
CCI clears merger of nine pharma entities with Sequent Scientific
The Competition Commission of India has approved the amalgamation of nine entities into Sequent Scientific Ltd (SSL), enhancing its position in the animal and human healthcare sectors. Furthermore, CCI has cleared the acquisition of AI Lenarco Midco by Majesty II Pte Ltd, including investments in Manjushree Technopack, thereby strengthening the involved...
Glenmark launches generic anticoagulant injectable emulsion
Glenmark Pharmaceuticals has launched Phytonadione injectable emulsion through its US arm, targeting anticoagulant markets. The 10 mg/mL single-dose ampules are bioequivalent to Vitamin K1 Injectable Emulsion USP. This launch diversifies Glenmark's institutional product portfolio and reinforces their commitment to offering affordable alternatives,...
Indian drugmakers likely to gain under the new US government
Industry experts are hopeful of India's trajectory as the US is facing shortages and backorders. They said with many blockbuster drugs were going off-patent between 2025 and 2029. "The Indian pharma industry will have a further growth opportunity in the form of generics."
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tgOescK
via ...
Jupiter Hospital to invest Rs 400 crore to set up new hospital in Ghodbunder-Mira Road
Jupiter Life Line Hospitals has acquired land in Thane to build a 300-bed hospital at an investment of Rs. 400 crore. The new hospital, planned over four years, aims to serve underserved regions. Jupiter, with 1061 beds, plans to expand its capacity to 2500 beds and is investing in new projects in Pune and Dombivli.
from Healthcare/Biotech-Industry-Economic...
Kamal Hinduja’s insights on combating India’s rising lung disease crisis
The rise in lung-related disorders in India is exacerbated by air pollution, tobacco use, and traditional cooking methods. Kamal Hinduja highlights the need for preventive measures, improved air quality, and reduction of tobacco use. The Hinduja Group, through P.D. Hinduja Hospital, is addressing these issues with awareness campaigns, advanced treatments,...
Biocon urges government to exempt cancer, rare-disease drugs from tax in budget
India should eliminate tax on drugs for cancer treatment and chronic diseases, urged Biocon's chairperson Kiran Mazumdar-Shaw, ahead of the budget. She highlighted the heavy financial burden on patients and called for making lifesaving therapies affordable by removing taxes and cutting import duties on medical equipment.
from Healthcare/Biotech-Industry-Economic...
Bengaluru company launches low-cost treatment for blood cancer
Immuneel Therapeutics, co-founded by Kiran Mazumdar-Shaw, has introduced Qartemi, India's second CAR-T cell therapy, to treat B-cell Non-Hodgkin Lymphoma. This therapy is priced at a fraction of similar treatments in the West and offers a new option for aggressive blood cancers.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aN72ZvG
via...
Private hospital in Kolkata launches rooftop helipad for emergency services
Kolkata's Desun Hospital successfully conducted a trial run of its newly launched rooftop helipad with an Agusta 109 SP helicopter, enhancing emergency healthcare services. Approved by the DGCA, the helipad aims to provide critical care air ambulance services for patients across West Bengal, North-East, and Eastern India, ensuring faster medical intervention.
from...
Halt illegal imports of refurbished medical gear: Drug regulator
India's drug regulator has instructed Customs to prevent the entry of refurbished medical devices, as these lack regulation under existing rules. This move addresses concerns about patient safety and supports domestic manufacturers. Imports are halted until a policy framework is established, impacting the pre-owned medical equipment market, which aids...
Competition Commission of India penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal
The Competition Commission of India has imposed a Rs 40 lakh penalty on Goldman Sachs AIMPL for not notifying the regulator about a deal involving optionally convertible debentures issued by Biocon Biologics. CCI ruled the deal was strategic and required prior approval.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Qp1iXRJ
via IF...
A Healthy Dialogue: Future of health sector cooperation under the Trump administration
India faces a complex health cooperation agenda with the incoming US administration. Key focus areas include trade in pharmaceuticals, pandemic preparedness, vaccine development, digital health, and climate resilience in health systems. Ensuring continued collaboration and addressing emerging challenges requires strategic planning and negotiation.
from...
Clear labelling of industrial & medical oxygen must, PMO tells health ministry
The Prime Minister's Office has instructed the health ministry to ensure proper labelling of oxygen cylinders to differentiate medical oxygen from industrial oxygen. This action follows concerns raised by lawmaker Ajeet Madhavrao Gopchade about the importance of quality medical oxygen to prevent infections and health complications in patients, especially...
Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talent
Takeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, and cybersecurity. The facility aims to advance AI in drug discovery, clinical trials, and patient care. The company plans to launch its Dengue vaccine in India by 2026 and expand its focus on inflammation, oncology, and rare conditions.
from...
Alembic Pharmaceuticals gets USFDA nod for generic antidepressant tablets
Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in treating major depressive disorder and schizophrenia. The approval covers strengths from 0.25 mg to 4 mg, and the market size for these tablets is estimated at USD 2 billion for the year ending September 2024.
from Healthcare/Biotech-Industry-Economic...
Tata Group and IISc partner to establish medical school to pioneer healthcare education and research
The Tata Group has partnered with the Indian Institute of Science (IISc) to establish the Tata IISc Medical School on the IISc Bengaluru campus with a contribution of Rs 500 crore. The school aims to integrate clinical research and medical education through innovative degree programs and global collaborations, focusing on various medical specialities.
from...
Quadria Capital buys 10% stake in pharma company Aragen Life Sciences for $100 million
Aragen Life Sciences secured a $100 million investment from Quadria Capital, selling a 10% stake at a $1.4 billion valuation. This funding supports strategic expansion to meet demand from US and European innovators. Aragen revenue for FY24 and FY25 is projected at Rs 1,675 crore and Rs 1,800 crore respectively.
from Healthcare/Biotech-Industry-Economic...
Healthcare Industry seeks tax cuts on insurance premiums & increased budgetary allocation in Budget 2025
Industry experts expect the 2025 Union Budget to include reforms for the healthcare sector. They seek increased government spending, focus on preventive healthcare, tax uniformity, and better insurance policies. Stakeholders hope for measures to improve healthcare infrastructure, especially in rural areas, and initiatives to support urban low-income...
AIG Hospitals to invest Rs 800 crore in new oncology centre
AIG Hospitals is investing Rs 800 crore in a new dedicated oncology centre in Hyderabad, featuring the cutting-edge Proton Beam Therapy system from Belgium-based IBA. This marks a significant milestone in delivering advanced cancer care in India, especially for treating complex tumours near critical organs.
from Healthcare/Biotech-Industry-Economic...
Pharma lobby seeks 2-year extension of schedule M deadline
Pharma lobby group FOPE has requested the government to extend the compliance deadline for the revised Schedule M till December 31, 2026. This is to allow manufacturers time to make necessary upgrades. The government is currently considering a draft notification suggesting an extension until December 31, 2025, for smaller manufacturers.
from Healthcare/Biotech-Industry-Economic...
Practo reports 22pc rise in revenue in FY24, GMV crosses Rs 3,500 crore
Practo, a health-tech platform, reported a 22% revenue growth to Rs 240 crore for the 2023-24 financial year, achieving a GMV of Rs 3,500 crore. The company reduced its losses to Rs 17 crore and had its first profitable quarter. Practo focuses on improving healthcare outcomes and expanding its presence in India and abroad.
from Healthcare/Biotech-Industry-Economic...
Kotak Strategic Situations Fund buys into Neuberg Diagnostics
Kotak Strategic Situations India Fund II has invested Rs 940 Crore in Neuberg Diagnostics to support its inorganic expansion and prepare for its IPO. Neuberg aims to enhance personalized medicine and integrated diagnostics, with a strong network and market leadership in India.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HFTo0Nl
via...
Navigating cardiovascular risk in people with type 2 diabetes mellitus
The prevalence of Type 2 Diabetes Mellitus (T2DM) is rising globally, increasing cardiovascular disease (CVD) risk. Effective management strategies should include comprehensive control of blood glucose, blood pressure, and lipid levels, lifestyle changes, and the use of anti-diabetic medications to reduce CV events.
from Healthcare/Biotech-Industry-Economic...
Budget 2025: Tax cuts, sops on Pharma Inc's wish list
Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax exemptions on life-saving drugs in the upcoming Union budget. They want more oncology drugs to be tax-exempt and lower customs duties on essential medical equipment. Executives also propose incentives for AI research and standardization...
India, Dominican Republic packaged deadly synthetic opioids into pills: US report warns of risks from online pharmacies
Nearly 35,000 online pharmacies worldwide are operating illegally, risking the distribution of ineffective or dangerous drugs, says the U.S. Trade Representative's report. The report highlights concerns about counterfeits from 19 countries and names notorious markets and platforms involved in such activities, particularly across Asia and the United...
US pharma major Eli Lilly and Co plans to establish new GCC in Hyderabad
US pharma company Eli Lilly plans to open a new global capability centre in Hyderabad by mid-2025. It will recruit over 1,000-1500 skilled workers, including technology engineers and data scientists. The centre will focus on expanding capabilities in automation, artificial intelligence, software product engineering, and cloud computing to support Lilly's...
Centre may decide on rollout of Schedule M by next week
The government is set to decide on implementing the revised Schedule M for pharmaceutical products by next week. While pharma groups have requested a two-year extension, no formal feedback for this has been received. The health ministry's draft notification suggests a year's extension, with a deadline for comments until January 11.
from Healthcare/Biotech-Industry-Economic...
Chemists’ apex body against RailTel’s plan to get bids from e-pharma
In a letter to the Union minister for Railways, AIOCD President JS Shinde said that e-pharmacies are operating illegally in the country. "The High Court has prohibited operations of online pharmacies. The Central Drugs Standard Control Organization (CDSCO) in its affidavit has admitted that there is no provision for online pharmacies in India at present...
HMPV: Drug supplies from China not likely to be affected by virus
Mehul Shah, pharma expert said the operations in China have not been affected and the situation is under control. "As we all know that this virus does not cause severity, trade is unlikely to get impacted," said another expert. India is dependent on China for all major essential medicines like paracetamol, anti acid (ranitidine), cardiovascular drugs...
Botanic Healthcare raises Rs 250 crore from Stakeboat Capital & other investors
Botanic Healthcare, a nutraceutical maker based in Hyderabad, has successfully raised Rs. 250 crores in its latest equity funding round led by Stakeboat Capital, with participation from Abakkus Four2Eight Opportunities Fund and DS Group. The funds will support the company's aggressive expansion plans and growth targets in the global nutraceutical market.
from...
Alkem Laboratories to sell Pithampur unit for Rs 149 crore
Alkem Laboratories Ltd agrees to sell its manufacturing facility in Pithampur, Madhya Pradesh, to Rubicon Research Ltd for Rs 149 crore via a slump sale. The transaction supports Alkem's strategy of optimizing manufacturing facilities. Rubicon will take over the development, manufacture, distribution, and sale of pharmaceutical formulations.
from...
Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formulary
Zydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to CVS’s template formulary starting January 1, 2025. This collaboration validates Zydus' new drug applications portfolio and aims to improve access to high-quality medications for patients.
from Healthcare/Biotech-Industry-Economic...
Biosimilar brand buy to help Intas Pharma take on biggies
In one of the biggest deals worldwide for a biosimilar brand, Ahmedabad-based Intas agreed to buy Udenyca-the brand name for medication pegfilgrastim-cbqv-from US-based Coherus BioSciences. Udenyca will be sold in the US by Accord BioPharma, the specialty division of Intas Pharma.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NPaOJ0H
via...
Cipla rolls out mobile application for asthma screening
Cipla has launched a mobile app, CipAir, to facilitate early screening for asthma in India. The app addresses the significant asthma burden in the country, aiding in better diagnosis and treatment. Initially available on Android, it will soon be rolled out on iOS devices as well.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4adTfgC
via...
Govt grants pharma industry 12-month extension for implementing revised Schedule M
The government has extended the deadline for pharma companies to implement updated quality standards by 12 months. This extension helps smaller manufacturers upgrade facilities and meet revised Schedule M requirements. The industry initially sought a two-year extension to address challenges. Firms must now comply with improved manufacturing practices...
Study estimates about a quarter of Indian population can access stroke facility in an hour
A study finds that only a quarter of India's population can access a stroke rehabilitation centre within an hour. The research highlights the lack of facilities, with less than one ischaemic stroke centre per million people. Improvements in infrastructure are urgently needed to enhance treatment outcomes.
from Healthcare/Biotech-Industry-Economic...
5,000 drug manufacturing units may miss Schedule M deadline, industry seeks extension
Nearly half of India's 10,000 drug manufacturing units might not meet the 2025 deadline for upgrading to revised Schedule M standards, risking closure. Currently, only 2,000 comply with good manufacturing practices. The industry seeks a two-year extension for improvements, but the government hasn't announced one yet. Audits and inspections may begin...
India's first Robotic-assisted Paediatric Gait Trainer for physical rehabilitation launched
Genrobotics launched India's first robotic-assisted Paediatric Gait Trainer, G-Gaiter Paediatric. It aims to improve physical rehabilitation for children with mobility issues. The device uses advanced VR technology and interactive games for therapy. Health Minister Veena George announced its installation at SAT Hospital in Thiruvananthapuram, enhancing...
“Nothing to be alarmed”: Health Ministry eases fears as China battles surge in respiratory virus
China is seeing a surge in infections caused by human metapneumovirus (HMPV), mostly in children under 14. Despite the uptick, the Indian health ministry states there is no cause for alarm, with no substantial increase in respiratory outbreaks within the country and prepared healthcare systems.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ocJjpu
via...
DJ Group of Institutions attains net debt-free status
DJ Group of Institutions, despite the challenges following the founder's death and regulatory changes, has achieved financial stability under Rhitik Jassar's leadership, turning from a ₹215 crore debt to net debt-free status. Their financial discipline, operational excellence, and strategic financial management have garnered recognition and continued...
Big public health upgrade in works; govt hospitals could soon get more firepower
The National Essential Diagnostics List will work as a guide for health facilities in India. It suggests basic tests for village-level centres and more advanced tests for Ayushman Arogya Mandirs and primary health centres. These guidelines aim to improve timely diagnosis and treatment, especially in rural areas.
from Healthcare/Biotech-Industry-Economic...